Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Cancer Research|September 23, 2003
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formationDorina Belotti, Paola Paganoni, Luigi Manenti, et al.
Carcinogenesis|December 14, 2018
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanomaLaura Carminati, Denise Pinessi, Patrizia Borsotti, et al.
Neoplasia (New York, N.Y.)|May 14, 2008
Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesiclesIlaria Giusti, Sandra D'Ascenzo, Danilo Millimaggi, et al.
Oncology Letters|June 28, 2016
Snail levels control the migration mechanism of mesenchymal tumor cellsCristina Belgiovine, Giulio Chiesa, Ilaria Chiodi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Potential antagonism of tubulin-binding anticancer agents in combination therapiesGiulia Taraboletti, Gianluca Micheletti, Romina Dossi, et al.
Bioorganic Chemistry|April 21, 2023
Identification of a novel extracellular inhibitor of FGF2/FGFR signaling axis by combined virtual screening and NMR spectroscopy approachKatiuscia Pagano, Roberta Listro, Pasquale Linciano, et al.
Clinical & Experimental Metastasis|July 18, 2015
Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatinAlessandra Decio, Marta Cesca, Francesca Bizzaro, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pHGiulia Taraboletti, Sandra D'Ascenzo, Ilaria Giusti, et al.
Cells|April 17, 2020
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with ChemotherapyAndrea Resovi, Patrizia Borsotti, Tommaso Ceruti, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2006
Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical developmentAnna Kruczynski, Maura Poli, Romina Dossi, et al.
Pageof 6